SEC Form 3 · accession 0000310158-26-000225
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gaurav K Gupta
Officer — EVP, CIDO
Period of report
Sep 1, 2026
Accepted (ET)
Sep 1, 2026 · 3:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1 | — | holding | — | — | — | Aug 7, 2027 | Aug 7, 2029 | Common Stock | 19,443 | — | D |
Explanation of responses
- F1These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/7/2027, 8/7/2028, and 8/7/2029.
- F2Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
Remarks
See Exhibit 24 - Power of Attorney